142 related articles for article (PubMed ID: 15354986)
21. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
22. Sevelamer hydrochloride with or without alphacalcidol or higher dialysate calcium vs calcium carbonate in dialysis patients: an open-label, randomized study.
Sadek T; Mazouz H; Bahloul H; Oprisiu R; El Esper N; El Esper I; Boitte F; Brazier M; Moriniere P; Fournier A
Nephrol Dial Transplant; 2003 Mar; 18(3):582-8. PubMed ID: 12584283
[TBL] [Abstract][Full Text] [Related]
23. [Sarcoidosis with hypercalcemia and increased 1 alpha, 25-dihydroxyvitamin D in lung tissue].
Fujita A; Suzuki A; Kashiyama T; Watanabe A; Kimura H
Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Aug; 33(8):900-5. PubMed ID: 7474574
[TBL] [Abstract][Full Text] [Related]
24. Unusual cause of hypercalcaemia in end stage renal failure patients.
Teo HK; Wong J
Hemodial Int; 2017 Apr; 21(2):E40-E44. PubMed ID: 27866377
[TBL] [Abstract][Full Text] [Related]
25. Hypercalcemia secondary to leprosy.
Couri CE; Foss NT; Dos Santos CS; de Paula FJ
Am J Med Sci; 2004 Dec; 328(6):357-9. PubMed ID: 15599334
[TBL] [Abstract][Full Text] [Related]
26. Primary hyperparathyroidism and severe hypercalcemia with low circulating 1,25-dihydroxyvitamin D.
Shaker JL; Krawczyk KW; Findling JW
J Clin Endocrinol Metab; 1990 Nov; 71(5):1305-9. PubMed ID: 2229288
[TBL] [Abstract][Full Text] [Related]
27. 1,25-Dihydroxyvitamin D-mediated hypercalcemia in oleogranulomatous mastitis (paraffinoma), ameliorated by glucocorticoid administration.
El Muayed M; Costas AA; Pick AJ
Endocr Pract; 2010; 16(1):102-6. PubMed ID: 19625241
[TBL] [Abstract][Full Text] [Related]
28. [Hypercalcemia in a female patient with chronic kidney failure secondary to sarcoidosis: a metabolic study of the calcium metabolism and bone histology].
Caravaca F; Cubero JJ; de Francisco AL; Arrobas M; Pizarro JL; Sánchez-Casado E
Med Clin (Barc); 1991 May; 96(17):659-61. PubMed ID: 2056801
[TBL] [Abstract][Full Text] [Related]
29. Anaplastic large cell lymphoma, with 1,25(OH)
Mitobe M; Kawamoto K; Suzuki T; Kiryu M; Nanba A; Suwabe T; Tanaka T; Fuse K; Shibasaki Y; Masuko M; Miyoshi H; Ohshima K; Sone H; Takizawa J
J Clin Exp Hematop; 2019; 59(1):22-28. PubMed ID: 30918141
[TBL] [Abstract][Full Text] [Related]
30. [Circulating metabolites of vitamin D in 14 children with hypercalcemia].
Jacqz E; Garabedian M; Guillozo H; Bourdeau A; Guillot M; Gagnadoux MF; Broyer M; Lenoir G; Balsan S
Arch Fr Pediatr; 1985 Mar; 42(3):225-30. PubMed ID: 3873927
[TBL] [Abstract][Full Text] [Related]
31. Hydroxychloroquine treatment of hypercalcemia in a patient with sarcoidosis undergoing hemodialysis.
Barré PE; Gascon-Barré M; Meakins JL; Goltzman D
Am J Med; 1987 Jun; 82(6):1259-62. PubMed ID: 3605143
[TBL] [Abstract][Full Text] [Related]
32. Symptomatic hypercalcemia of immobilization in a patient with end-stage renal disease.
Gopal H; Sklar AH; Sherrard DJ
Am J Kidney Dis; 2000 May; 35(5):969-72. PubMed ID: 10793036
[TBL] [Abstract][Full Text] [Related]
33. Hyperparathyroid bone disease in diabetic renal failure.
Cundy TF; Humphreys S; Watkins PJ; Parsons V
Diabetes Res; 1990 Aug; 14(4):191-6. PubMed ID: 2132193
[TBL] [Abstract][Full Text] [Related]
34. Hypercalcemia due to excess 1,25-dihydroxyvitamin D in Crohn's disease.
Tuohy KA; Steinman TI
Am J Kidney Dis; 2005 Jan; 45(1):e3-6. PubMed ID: 15696436
[TBL] [Abstract][Full Text] [Related]
35. Hypercalcemia associated with tertiary hyperparathyroidism managed conservatively with pamidronate in a hemodialysis patient.
Czosnowski LM; Hudson JQ; Canada RB
Am J Med Sci; 2009 Apr; 337(4):300-1. PubMed ID: 19365180
[TBL] [Abstract][Full Text] [Related]
36. Abnormal calcium homeostasis in disabled stroke patients with low 25-hydroxyvitamin D.
Sato Y; Kaji M; Honda Y; Hayashida N; Iwamoto J; Kanoko T; Satoh K
Bone; 2004 Apr; 34(4):710-5. PubMed ID: 15050902
[TBL] [Abstract][Full Text] [Related]
37. Hypercalcemia and elevated 1,25-(OH)2D levels in a patient with end-stage renal disease and active tuberculosis.
Fuss M; Karmali R; Bergman P; Gillet C; Prigogine T; Schmerber J; Brauman H; Corvilain J; Dierckx P
N Engl J Med; 1985 Jun; 312(23):1520-1. PubMed ID: 3838800
[No Abstract] [Full Text] [Related]
38. Diffuse calcinosis and intradermal tophi in a uremic pateint: effect of low-calcium hemodialysis and mechanism of hypercalcemia.
Hsu SC; Lee YY; Wang MC; Liu HL; Cheng MF; Huang JJ
Blood Purif; 2004; 22(2):224-8. PubMed ID: 15044822
[TBL] [Abstract][Full Text] [Related]
39. [Vitamin A poisoning revealed by hypercalcemia in a child with kidney failure].
Doireau V; Macher MA; Brun P; Bernard O; Loirat C
Arch Pediatr; 1996 Sep; 3(9):888-90. PubMed ID: 8949352
[TBL] [Abstract][Full Text] [Related]
40. [Recurrence of sarcoidosis in a hemodialysis patient confirmed by abnormal calcium metabolism].
Tanaka K; Tanimoto H; Sakai K; Arai K; Mizuiri S; Hasegawa A; Otsuka T; Uchino M
Clin Calcium; 2005 Sep; 15 Suppl 1():83-5; discussion 86. PubMed ID: 16272637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
